Perficient: Drug Development

DECEMBER 12, 2024

Welcome to 2025, where Salesforces Einstein GPT is transforming CRM as we know it. Whats New in 2025? Heres what makes it even better in 2025: Deeper Integrations : Einstein GPT now works seamlessly across all Salesforce CloudsSales, Marketing, Service, and more. Your CRM didnt just sit thereit worked while you slept.

Marketing 52

Marketing Production 52

BioPharma Drive: Drug Pricing

JUNE 10, 2024

Positive results from the trial could position Moderna to bring the two-in-one vaccine to market in 2025.

Vaccine 122

Vaccine Trials Marketing 122

BioPharma Drive: Drug Pricing

JULY 31, 2024

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

RNA 119

RNA Treatment 119

Fierce BioTech

OCTOBER 15, 2024

A Pharma Marketers' Roadmap to Data Privacy Compliance : Are You Ready for 2025? swheeler Tue, 10/15/2024 - 19:53 Thu, 11/21/2024 - 13:00 Resource Type Webinar Ben Chapman Duration 60 minutes Join for an insightful webinar on the evolving privacy landscape impacting pharma marketers in 2025.

Compliance 52

Compliance Marketing Regulations 52

BioPharma Drive: Drug Pricing

AUGUST 21, 2024

Pharmaceuticals like the in-demand GLP-1 drugs for obesity are expected to drive increases in healthcare spending in 2025, per a new employer survey.

Pharmacy 115

Pharmacy Pharmaceuticals Drugs 115

Crown Bioscience

NOVEMBER 14, 2024

As we approach 2025, biomarker analysis in the preclinical stage is poised for transformative changes, driven by advances in technology, data science, and evolving regulatory frameworks.

Clinical Research 59

Clinical Research Research Science 59

Advarra

DECEMBER 17, 2024

As we look to 2025, Advarra thought leaders have compiled predictions and perspectives on key topics shaping the industry. The post 2025: Perspectives and Predictions From Advarra Thought Leaders appeared first on Advarra. 2024 has been a year of growth and evolution in clinical research.

Clinical Research 52

Clinical Research Clinical Trials Trials Hospitals 52

FDA Law Blog: Biosimilars

SEPTEMBER 4, 2024

HP&M”) is proud to announce that 16 of the Firm’s attorneys have been selected to the 2025 edition of The Best Lawyers in America®. Hyman has been rightfully chosen as a 2025 “Lawyer of the Year.” Hyman, Phelps & McNamara, P.C. (“HP&M”) Founding Director Paul M. Additionally, Kalie E. Richardson, James E.

FDA 52

FDA 52

Drugs.com

JULY 25, 2024

THURSDAY, July 25, 2025 -- Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.These dual-action antibiotics, called macrolones, disrupt.

113

113

Fierce BioTech

OCTOBER 17, 2024

Takeaways: A closer look at how pharmaceutical marketers can enhance 2025 media strategies and planning by leveraging more sophisticated audience profiling techniques. The importance of balancing privacy with the need for deeper insights into patient behaviors and demographics in an increasingly crowded media environment.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Marketing 52

BioPharma Drive: Drug Pricing

OCTOBER 18, 2024

Detailed data from a Phase 2b/3 study of Merck’s treatment clesrovimab should support the company’s efforts to win approval by the 2025-2026 season.

Hospitals 111

Hospitals Disease Trials Treatment 111

BioPharma Drive: Drug Pricing

DECEMBER 17, 2024

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.

FDA 72

FDA FDA Approval Virus Drugs 72

BioPharma Drive: Drug Pricing

OCTOBER 4, 2023

The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025.

Vaccine 116

Vaccine Trials 116

Drug Channels

NOVEMBER 13, 2024

For 2025, DCI’s exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that the number of PDPs will drop to a historic low. The 2025 decline will occur even after CMS gifted $7 billion to PDPs to prevent a complete collapse of the 2025 market. What else should you expect for 2025?

Pharmacy 86

Pharmacy Marketing Drugs 86

Drugs.com

DECEMBER 26, 2024

26, 2025 -- Very early-stage breast cancers are notoriously tough to spot via mammograms, but new technology might make detection easier. WEDNESDAY, Dec. According to a new study published recently in the Journal of Biophotonics, Scottish.

86

86

Conversations in Drug Development Trends

NOVEMBER 5, 2024

In preparation for World Orphan Drug Congress Europe, we interviewed Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, and Derek Ansel, MS, LCGC, Vice President, Therapeutic Strategy Lead, Rare Disease, to hear their insights into the current progress in rare disease research and their hopes for 2025.

Disease 52

Disease Clinical Trials Therapies Clinical Research 52

Drugs.com

DECEMBER 27, 2024

27, 2024 -- Should you cut back on doom scrolling in 2025?Worries FRIDAY, Dec. Worries about money, gun violence and hate crimes ranked high among many people's lists of worries at the end of 2024, according to a poll that is part of American Psychiatric.

84

84

Drugs.com

MARCH 26, 2024

TUESDAY, March 26, 2025 -- A protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says.The naturally occurring protein, called Piezo1, prevents a type of immune cell called type 2 innate.

Research 96

Research Treatment 96

Perficient: Drug Development

NOVEMBER 15, 2024

Our experts are closely monitoring eight healthcare trends that are shaping industry leaders’ strategies in 2025. 2025 will see the continued push to meet healthcare consumers’ demand for convenience and personalized digital experiences. And this year is especially interesting, as 2024’s U.S. billion by 2030.

Regulations 64

Regulations Compliance Production Nurses 64

Drugs.com

OCTOBER 27, 2024

28, 2025 -- Halloween is meant to be a spooky season, but it can be downright terrifying to someone suffering from Alzheimer’s disease or dementia.“Halloween MONDAY, Oct. Halloween is full of scary sights and frightful sounds that create additional cha.

Disease 93

Disease 93

Science Daily: Pharmacology News

JANUARY 19, 2024

The new insulin is ready to be tested on humans in 2025. The medication that can be taken orally has already been tested on baboons, in which it was found to lower the blood sugar levels without causing hypoglycemia. If all goes well, diabetics are facing an easier life without injections.

Research 96

Research 96

keypoint

AUGUST 21, 2024

Conferences in our 2025 Health Equity Series will feature programming that showcases how scientists are bringing molecular, cellular, and genetic approaches to bear on health equity research and outcomes. This year we are expanding this pilot program to include over a dozen conferences in our portfolio!

Disease 40

Disease Research 40

Quanticate

SEPTEMBER 13, 2024

In our article, we cover the key trends that have been shaping clinical trials so far in 2024, and those that are predicted to continue into 2025.

Clinical Trials 95

Clinical Trials Trials Drug Development Treatment 95

keypoint

DECEMBER 20, 2024

Keystone Symposia CEO shares his first impressions, improvement and initiatives that will be implemented in 2025.

74

74

Perficient: Drug Development

NOVEMBER 15, 2024

Our experts are closely monitoring eight healthcare trends that are shaping industry leaders’ strategies in 2025. 2025 will see the continued push to meet healthcare consumers’ demand for convenience and personalized digital experiences. And this year is especially interesting, as 2024’s U.S. billion by 2030.

Regulations 52

Regulations Compliance Production Nurses 52

Drug Channels

NOVEMBER 19, 2024

In Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market , I documented the Inflation Reduction Act’s (IRA) disruption to Medicare Part D prescription drug plans (PDPs). As always, we provide you with a handy table for tallying each chain’s participation and changes from 2024 to 2025. Fein, Ph.D.,

Pharmacy 75

Pharmacy Marketing Drugs 75

Covalent Modifiers

DECEMBER 28, 2024

Ai-Lin Chen, Zih-Jheng Lin, Hsiao-Yu Chang, and Tsung-Shing Andrew Wang Journal of the American Chemical Society , 2025 [link] Reactive carbonyl species (RCS) are important biomarkers of oxidative stress-related diseases because of their highly reactive electrophilic nature.

Disease 71

Disease Production 71

FDA Law Blog: Biosimilars

SEPTEMBER 11, 2024

Last week’s guidance is featured on FDA’s new nitrosamines webpage and recommends that manufacturers implement revisions to control measures by August 1, 2025, noting that manufacturers and sponsors of approved products were expected to complete evaluations for small molecule nitrosamines last year.

Small Molecule 105

Small Molecule FDA Production Drugs 105

SCIENMAG: Medicine & Health

MARCH 19, 2024

Credit: IVI IVI will complete the technology transfer by 2025 Oral Cholera Vaccine to be manufactured by Biological E.

Vaccine 82

Vaccine Marketing International 82

Drug Channels

NOVEMBER 7, 2024

Patient Support Programming in 2025 and Beyond. He then outlines three actions that should guide manufacturers' preparation. To learn more, register for ConnectiveRx’s free webinar on December 11: The Perfect Storm? Read on for Chris’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Marketing 74

Marketing Drugs 74

Agency IQ

JULY 22, 2024

Updated EUDAMED roadmap projects mandatory use of some processes as early as December 2025 The new EUDAMED roadmap includes updates accounting for the recent amendments to the European medical device and diagnostics regulations, which allow for a phased rollout of the different functional modules of the database. OJEU) around July 2025.

Regulations 40

Regulations Marketing Clinical Trials Trials 40

Agency IQ

JULY 22, 2024

BY COREY JASEPH, MS, RAC The new EUDAMED roadmap includes updates accounting for the recent amendments to the European medical device and diagnostics regulations, which allow for a phased rollout of the different functional modules of the database.

Regulations 59

Regulations 59

Drugs.com

DECEMBER 18, 2024

WEDNESDAY, Dec. 18, 2024 -- Folks need to act now if they want health insurance coverage starting Jan. 1 through an Affordable Care Act marketplace, officials and experts say.Wednesday is the last day folks can enroll in coverage that commences at.

52

52

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If If you sign up before 12 p.m. ET, you can attend the live event.) Click here to see the original post. spending on healthcare.

Government 80

Government Specialty Pharmacies Pharmacy Drugs 80

Fierce BioTech

SEPTEMBER 6, 2024

RWE Impact: When Empowered Patients Drive Pharma Outcomes pesurya Fri, 09/06/2024 - 11:33 Thu, 10/03/2024 - 11:00 Resource Type Webinar Leigh Ann Bruhn Arturo LoAIza-Bonilla MD Nico O'Kuinghttons Cathy Zaremba Promotion Start Mon, 09/09/2024 - 11:45 Promotion End Sun, 03/09/2025 - 11:45 Duration 60 Minutes Discover the transformative power of RWE.

Clinical Trials 98

Clinical Trials Therapies Trials Drugs 98

BioPharma Drive: Drug Pricing

SEPTEMBER 13, 2023

The digital therapeutics company expects to extend its cash runway into 2025 with the changes.

69

69

Antidote

NOVEMBER 15, 2024

Looking toward 2025, clinical trial sponsors must plan now and rethink their patient recruitment strategies to stay ahead of evolving technologies, regulations, and shifting patient expectations.

Clinical Trials 52

Clinical Trials Trials Regulations 52